Literature DB >> 27169531

Pigmented villonodular synovitis: a crowdsourcing study of two hundred and seventy two patients.

Lizz van der Heijden1, Sheila R Piner2, Michiel Adrianus Josephus van de Sande3.   

Abstract

PURPOSE: We aimed to ascertain the feasibility of crowdsourcing via Facebook for medical research purposes; by investigating surgical, oncological and functional outcome and quality-of-life (QOL) in patients with pigmented villonodular synovitis (PVNS) enrolled in a Facebook community (1112 members).
METHODS: Patients completed online open surveys on demographics, surgery and clinical outcomes (group 1); and patient-reported outcome measures (PROMs) including knee-injury osteoarthritis outcome score (KOOS), hip-disability osteoarthritis outcome score (HOOS), Toronto extremity salvage score (TESS) and SF-36 (group 2). Mean follow-up was 70 months (12-374). Consistency checks were performed with Cohen's kappa statistic for intra-rater agreement.
RESULTS: The first survey was completed by 272 patients (group 1) and 72 patients completed the second (group 2). In group 1, recurrence-rate was 58 % (69/118) after arthroscopic, 36 % (35/97) after open and 50 % (5/10) after combined synovectomy (p = 0.003). In group 2, recurrence-rate was 67 % (26/39) after arthroscopic and 51 % (17/33) after open synovectomy (p = 0.19). Recurrence-risk was increased for diffuse disease (OR = 16; 95%CI = 3.2-85; p < 0.001). Mean function and QOL did not differ after arthroscopic or open synovectomy: KOOS 49 vs. 58 (p = 0.24), HOOS 62 vs. 53 (p = 0.56), TESS 78 vs. 82 (p = 0.86), SF-36 61 vs. 66 (p = 0.41). Cohen's kappa statistic for intra-rater agreement was good to outstanding (κ = 0.68-0.95; p < 0.001).
CONCLUSION: Local recurrence-risk was higher for diffuse-type disease and arthroscopic synovectomy. Functional outcome and QOL were comparable for both types of surgery. Gathering data via crowdsourcing seems a promising and innovative way of evaluating rare diseases including PVNS.

Entities:  

Keywords:  Crowdsourcing; Diffuse-type giant cell tumor; Facebook; Functional outcome; PVNS; Pigmented villonodular synovitis; Quality of life

Mesh:

Year:  2016        PMID: 27169531     DOI: 10.1007/s00264-016-3208-1

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  39 in total

1.  Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations.

Authors:  N K Aaronson; M Muller; P D Cohen; M L Essink-Bot; M Fekkes; R Sanderman; M A Sprangers; A te Velde; E Verrips
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

Review 2.  Clinical results of open synovectomy for treatment of diffuse pigmented villonodular synovitis of the knee: case series and review of literature.

Authors:  Hiroyuki Nakahara; Shuichi Matsuda; Katsumi Harimaya; Akio Sakamoto; Yoshihiro Matsumoto; Ken Okazaki; Yasutaka Tashiro; Yukihide Iwamoto
Journal:  Knee       Date:  2012-01-20       Impact factor: 2.199

Review 3.  The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis).

Authors:  L van der Heijden; C L M H Gibbons; P D S Dijkstra; J R Kroep; C S P van Rijswijk; R A Nout; K M Bradley; N A Athanasou; P C W Hogendoorn; M A J van de Sande
Journal:  J Bone Joint Surg Br       Date:  2012-07

4.  Long-term results of surgical treatment of pigmented villonodular synovitis of the knee.

Authors:  Orhan Akinci; Yavuz Akalin; Mustafa İncesu; Ahmet Eren
Journal:  Acta Orthop Traumatol Turc       Date:  2011       Impact factor: 1.511

5.  Simultaneous anterior and posterior synovectomies for treating diffuse pigmented villonodular synovitis.

Authors:  Wei-Ming Chen; Po-Kuei Wu; Chien-Lin Liu
Journal:  Clin Orthop Relat Res       Date:  2012-02-23       Impact factor: 4.176

6.  Treatment of diffuse pigmented villonodular synovitis of the knee with combined surgical and radiosynovectomy.

Authors:  Wael A M Nassar; Ayman Abdelaziz Bassiony; Hesham A Elghazaly
Journal:  HSS J       Date:  2008-12-19

7.  Arthroscopic synovectomy in pigmented villonodular synovitis of the knee: clinical series and outcome.

Authors:  Jitesh K Jain; J V S Vidyasagar; Radha Sagar; Hiren Patel; Matad Lokeshwaraiah Chetan; Ashish Bajaj
Journal:  Int Orthop       Date:  2013-07-17       Impact factor: 3.075

8.  Long-term follow-up of surgically treated localized pigmented villonodular synovitis of the knee.

Authors:  Joshua S Dines; Thomas M DeBerardino; Jason L Wells; Christopher C Dodson; Michael Shindle; Edward F DiCarlo; Russell F Warren
Journal:  Arthroscopy       Date:  2007-09       Impact factor: 4.772

9.  Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES).

Authors:  Gunther Eysenbach
Journal:  J Med Internet Res       Date:  2004-09-29       Impact factor: 5.428

Review 10.  Subjects no more: what happens when trial participants realize they hold the power?

Authors:  Paul Wicks; Timothy Vaughan; James Heywood
Journal:  BMJ       Date:  2014-01-28
View more
  14 in total

1.  Arthroscopically-assisted mini open partial synovectomy for the treatment of localized pigmented villonodular synovitis of the knee. A retrospective comparative study with long-term follow up.

Authors:  Dimitrios Georgiannos; Achilleas Boutsiadis; Filon Agathangelidis; Stergios Papastergiou; Dimitrios Karataglis; Ilias Bisbinas
Journal:  Int Orthop       Date:  2016-11-19       Impact factor: 3.075

2.  Immune Cell Infiltration Characteristics of Pigmented Villous Nodular Synovitis and Prediction of Potential Diagnostic Markers Based on Bioinformatics.

Authors:  Jun Zhang; Bin Li; Boming Zhao; Yongjian Qi; Liaobin Chen; Jun Chen; Biao Chen
Journal:  Biomed Res Int       Date:  2022-06-07       Impact factor: 3.246

3.  IT-based Psychosocial Distress Screening in Patients with Sarcoma and Parental Caregivers via Disease-specific Online Social Media Communities.

Authors:  Florian Pohlig; Ulrich Lenze; Heinrich M L Muhlhofer; Florian W Lenze; Johannes Schauwecker; Carolin Knebel; Tanja Zimmermann; Peter Herschbach
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

4.  Arthroscopic synovectomy of the knee joint for rheumatoid arthritis.

Authors:  Marina Lipina; Maxim Makarov; Victor Mukhanov; Alexander Karpashevich; Sergey Maglevaniy; Vera Amirdjапоvа; Sergey Archipov
Journal:  Int Orthop       Date:  2018-10-03       Impact factor: 3.075

5.  Recurrence of giant cell tumour of bone: role of p53, cyclin D1, β-catenin and Ki67.

Authors:  Nenad Lujic; Jelena Sopta; Relja Kovacevic; Vladan Stevanovic; Radoslav Davidovic
Journal:  Int Orthop       Date:  2016-09-22       Impact factor: 3.075

6.  cIAP2 expression and clinical significance in pigmented villonodular synovitis.

Authors:  Zhenyu Ding; Zhenlong Bai; Miao Zhang; Benben Sun; Yaohua He
Journal:  J Mol Histol       Date:  2021-02-18       Impact factor: 2.611

7.  Limb Amputation after Multiple Treatments of Tenosynovial Giant Cell Tumour: Series of 4 Dutch Cases.

Authors:  Monique J L Mastboom; Floortje G M Verspoor; Hans Gelderblom; Michiel A J van de Sande
Journal:  Case Rep Orthop       Date:  2017-06-28

8.  Use of Social Media in the Assessment of Relative Effectiveness: Explorative Review With Examples From Oncology.

Authors:  Rachel Rj Kalf; Amr Makady; Renske Mt Ten Ham; Kim Meijboom; Wim G Goettsch
Journal:  JMIR Cancer       Date:  2018-06-08

9.  Opportunities and pitfalls of social media research in rare genetic diseases: a systematic review.

Authors:  Emily G Miller; Amanda L Woodward; Grace Flinchum; Jennifer L Young; Holly K Tabor; Meghan C Halley
Journal:  Genet Med       Date:  2021-07-19       Impact factor: 8.864

10.  The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life.

Authors:  Monique Josephine Mastboom; Rosa Planje; Michiel Adreanus van de Sande
Journal:  Interact J Med Res       Date:  2018-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.